Long-term study of SMP-862 in patients with paediatric type 2 diabetes mellitus

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221475

Enrollment

Registered

2011-06-10

Start date

2011-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

investigational material(s) Generic name etc : SMP-862 (metformin hydrochloride) INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for In

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients who have undergone diet and exercise therapy prior to initiation of treatment - HbA1c immediately prior to enrolment is >= 7.0% etc.

Exclusion criteria

Exclusion criteria: - Patients receiving insulin therapy - Patients with moderate or severe renal dysfunction - Patients with severe hepatic dysfunction etc.

Design outcomes

Primary

Measure	Time frame
HbA1c Final visit	—

Secondary

Measure	Time frame
Glycoalbumin Final visit	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026